APA Цитирование

Cremolini, C., Benelli, M., Fontana, E., Pagani, F., Rossini, D., Fucà, G., . . . Pietrantonio, F. (2019). Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: A clinical and molecular proof of concept study. ESMO Open.

Chicago-стиль цитирования

Cremolini, Chiara, et al. "Benefit From Anti-EGFRs in RAS and BRAF Wild-type Metastatic Transverse Colon Cancer: A Clinical and Molecular Proof of Concept Study." ESMO Open 2019.

MLA-цитирование

Cremolini, Chiara, et al. "Benefit From Anti-EGFRs in RAS and BRAF Wild-type Metastatic Transverse Colon Cancer: A Clinical and Molecular Proof of Concept Study." ESMO Open 2019.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.